OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells

Meng,Lu; Hu,Hongyu; Zhi,Huifang; Liu,Yue; Shi,Fangyu; Zhang,Laiguang; Zhou,Yanjun; Lin,Aixing

doi:10.3892/ol.2018.8607

OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells

Authors:
- Lu Meng
- Hongyu Hu
- Huifang Zhi
- Yue Liu
- Fangyu Shi
- Laiguang Zhang
- Yanjun Zhou
- Aixing Lin
View Affiliations

Affiliations: Molecular/Cellular Biology & Animal Biotech, National Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, P.R. China
Published online on: May 2, 2018 https://doi.org/10.3892/ol.2018.8607
Pages: 522-528

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Octamer-binding transcription factor 4 (OCT4) is a transcription factor with a well‑defined role in stem cell pluripotency. Two OCT4 isoforms, OCT4A and OCT4B, tend to be downregulated as normal cells differentiate. However, OCT4, particularly OCT4B, may become reactivated in cancer cells. Despite this observation, the exact function of OCT4B re‑expression in cancer is unclear. In the present study, the role of OCT4 in breast cancer cells was determined. In particular, the ability of OCT4 to regulate key genes involved in cellular proliferation and apoptosis, two pathways that are frequently deregulated in cancer, was examined. The cyclin-dependent kinase inhibitor 2A locus encodes p16INK4a and p14ARF, two important cell cycle inhibitors. The tumor suppressor p53 also has well characterized roles in suppressing proliferation and promoting apoptosis. The present study demonstrated, via overexpression and genetic knockdown techniques, that OCT4B regulates the expression of several of these genes and ultimately regulates the rate of apoptosis of MCF‑7 breast cancer cells. It was also observed that, while OCT4B and OCT4A regulate one another, it is OCT4B that serves a more prominent role in regulating the transcription of downstream genes. Taken together, the present results suggest that OCT4B is re‑expressed in a number of breast cancer cell lines, where it affects both the transcription of cell cycle genes and the rate of apoptosis. These properties of OCT4B may depend on, at least in part, the co‑function of OCT4A.

View Figures

View References

1	Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions: Nature Rev Cancer. 8:755–768. 2008.
2	Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG and Di Fiore PP: Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 140:62–73. 2010. View Article : Google Scholar : PubMed/NCBI
3	Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K and Clarke MF: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med. 356:217–226. 2007. View Article : Google Scholar : PubMed/NCBI
4	Liu CG, Lu Y, Wang BB, Zhang YJ, Zhang RS, Lu Y, Chen B, Xu H, Jin F and Lu P: Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg. 253:1165–1171. 2011. View Article : Google Scholar : PubMed/NCBI
5	Niwa HJ, Miyazaki J and Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 24:372–376. 2000. View Article : Google Scholar : PubMed/NCBI
6	Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M and Hamada H: A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 60:461–472. 1990. View Article : Google Scholar : PubMed/NCBI
7	Monsef N, Soller M, Isaksson M, Abrahamsson PA and Panagopoulos I: The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia. Prostate. 69:909–916. 2009. View Article : Google Scholar : PubMed/NCBI
8	Atlasi Y, Mowla SJ, Ziaee SA and Bahrami AR: OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer. 120:1598–1602. 2007. View Article : Google Scholar : PubMed/NCBI
9	Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ and Andrews PW: OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells. 26:3068–3074. 2008. View Article : Google Scholar : PubMed/NCBI
10	Papamichos SI, Kotoula V, Tarlatzis BC, Agorastos T, Papazisis K and Lambropoulos AF: OCT4B1 isoform: The novel OCT4 alternative spliced variant as a putative marker of stemness. Mol Hum Reprod. 15:269–270. 2009. View Article : Google Scholar : PubMed/NCBI
11	Wang X and Dai J: Concise review: Isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells. 28:885–893. 2010.PubMed/NCBI
12	Lee J, Kim HK, Rho JY, Han YM and Kim J: The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem. 281:33554–33565. 2006. View Article : Google Scholar : PubMed/NCBI
13	Kotoula V, Papamichos SI and Lambropoulos AF: Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells. 26:290–291. 2008. View Article : Google Scholar : PubMed/NCBI
14	Gao Y, Wei J, Han J, Wang X, Su G, Zhao Y, Chen B, Xiao Z, Cao J and Dai J: The novel function of OCT4B isoform-265 in genotoxic stress. Stem Cells. 30:665–672. 2012. View Article : Google Scholar : PubMed/NCBI
15	Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD and Yang CS: Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res. 5:2704–2713. 1999.PubMed/NCBI
16	Li J, Poi MJ and Tsai MD: Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry. 50:5566–5582. 2011. View Article : Google Scholar : PubMed/NCBI
17	Sherr CJ: Autophagy by ARF: A short story. Mol Cell. 22:436–437. 2006. View Article : Google Scholar : PubMed/NCBI
18	Sherr CJ: Divorcing ARF and p53: An unsettled case. Nat Rev Cancer. 6:663–673. 2006. View Article : Google Scholar : PubMed/NCBI
19	Agrawal A, Yang J, Murphy RF and Agrawal DK: Regulation of the p14ARF-Mdm2-p53 pathway: An overview in breast cancer. Exp Mol Pathol. 81:115–122. 2006. View Article : Google Scholar : PubMed/NCBI
20	Fisher DE: The p53 tumor suppressor: critical regulator of life & death in cancer. Apoptosis. 6:7–15. 2001. View Article : Google Scholar : PubMed/NCBI
21	Haupt S, Berger M, Goldberg Z and Haupt Y: Apoptosis-the p53 network. J Cell Sci. 116:4077–4085. 2003. View Article : Google Scholar : PubMed/NCBI
22	Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
23	Cao Y, Siegel D and Knöchel W: Xenopus POU factors of subclass V inhibit activin/nodal signaling during gastrulation. Mech Dev. 123:614–625. 2006. View Article : Google Scholar : PubMed/NCBI
24	Cao Y, Knöchel S, Donow C, Miethe J, Kaufmann E and Knöchel W: The POU factor Oct-25 regulates the Xvent-2B gene and counteracts terminal differentiation in Xenopus embryos. J Biol Chem. 279:43735–43743. 2004. View Article : Google Scholar : PubMed/NCBI
25	Hinkley CS, Martin JF, Leibham D and Perry M: Sequential expression of multiple POU proteins during amphibian early development. Mol Cell Biol. 12:638–649. 1992. View Article : Google Scholar : PubMed/NCBI
26	Ng WL, Chen G, Wang M, Wang H, Story M, Shay JW, Zhang X, Wang J, Amin AR, Hu B, et al: OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation. Cell Death Dis. 5:e10242014. View Article : Google Scholar : PubMed/NCBI
27	Wang Y, Meng L, Hu H, Zhang Y, Zhao C, Li Q, Shi F, Wang X and Lin A: Oct-4B isoform is differentially expressed in breast cancer cells: Hypermethylation of regulatory elements of Oct-4A suggests an alternative promoter and transcriptional start site for Oct-4B transcription. Biosci Rep. 31:109–115. 2011. View Article : Google Scholar : PubMed/NCBI
28	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
29	Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR: The p53 network. J Biol Chem. 273:1–4. 1998. View Article : Google Scholar : PubMed/NCBI
30	Pesce M, Gross MK and Schöler HR: In line with our ancestors: Oct-4 and the mammalian germ. Bioessays. 20:722–732. 1998. View Article : Google Scholar : PubMed/NCBI
31	Schöler HR, Ruppert S, Suzuki N, Chowdhury K and Gruss P: New type of POU domain in germ line-specific protein Oct-4. Nature. 344:435–439. 1990. View Article : Google Scholar : PubMed/NCBI
32	Wang P, Branch DR, Bali M, Schultz GA, Goss PE and Jin T: The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem J. 375:199–205. 2003. View Article : Google Scholar : PubMed/NCBI
33	Li D, Yang ZK, Bu JY, Xu CY, Sun H, Tang JB, Lin P, Cheng W, Huang N, Cui RJ, et al: OCT4B modulates OCT4A expression as ceRNA in tumor cells. Oncol Rep. 33:2622–2630. 2015. View Article : Google Scholar : PubMed/NCBI
34	Sherr CJ and Weber JD: The ARF/p53 pathway. Curr Opin Genet Dev. 10:94–99. 2000. View Article : Google Scholar : PubMed/NCBI
35	Kim WY and Sharpless NE: The regulation of INK4/ARF in cancer and aging. Cell. 127:265–275. 2006. View Article : Google Scholar : PubMed/NCBI